Prostate cancer related marker and application thereof
A prostate cancer and marker technology, applied in the biological field, can solve the problems of human injury, cumbersome methods, and poor specificity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] The content of malic acid, 3-hydroxy-3-methylglutamic acid and DL-3-phenyl lactate in the serum of prostate patients and normal human controllers was detected by ultra-high performance liquid chromatography-tandem mass spectrometry (LC-MS / MS) method, as follows:
[0032] 1. Subject inclusion criteria
[0033] Normal human control (Control group) inclusion criteria: 1) normal rectal digital examination and prostate B ultrasound examination; 2) exclude urinary system diseases, exclude various benign and malignant tumors, and exclude various chronic diseases;
[0034]Patients with prostate cancer (PCa group) were included in the criteria: 1) serum prostate-specific antigen (PSA), digital rectal examination, prostate ultrasound, multiparametric magnetic resonance imaging scan and other examinations, and the pathology of prostate puncture biopsy was clearly diagnosed; there was no history of other systemic diseases and other malignant tumors; 2) the staging of prostate cancer wa...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com